Genetic testing should be used to help doctors spot high-risk cases of myeloma and enable targeted treatments, say researchers from the University of Leeds and The Institute of Cancer Research.
Blood cancer patients should be offered genetic testing to spot ‘double hit’ high-risk cases earlier
Offering state-of-the-art genetic testing to patients with the blood cancer myeloma would help doctors spot those with the most aggressive forms of the disease so that their cancer can be targeted ...
The NHS says it already offers some CAR-T therapies and is consulting on "potential future treatments". Only this week, the National Institute for Health and Care Excellence has recommended the use of ...
One of the key launch points for the modern biotechnology industry was not in the Bay Area or San Diego or Cambridge, ...
Hundreds of current and former federal employees rallied Wednesday outside the Department of Health and Human Services ...
Tampa General Hospital (TGH) today announced that Dr. Boris Naraev, a medical oncologist specializing in caring for patients living with gastrointestinal, neuroendocrine and endocrine tumors, has ...
Toutant is an assistant golf professional at Bishop's Bay ... stem cell transplant, and he continues to receive chemotherapy. His trip to The Masters was made possible through Nik's Wish, a nonprofit ...
When NSW mum Alana Hodgson first noticed something seemingly normal on her little girl, she thought little of it. Days later, ...
A woman who set up a business in West Sussex to stop unsold plants being thrown away during lockdown has been diagnosed with ...
And if we use senolytics, we see that the inflammation goes away and the regenerative capacity of the surrounding tissue is restored — well, at least if you’re a mouse.” Based on dozens of preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback